What Side Effects Can I Expect from Contrast Dye Used in a CT Scan?

Contrast-enhanced computed tomography (CT) relies on iodinated contrast media to improve visualization of blood vessels, organs, and pathological lesions. While generally safe and well-tolerated, these intravenous contrast agents can produce a spectrum of adverse effects—ranging from mild, transient reactions to rare but potentially life-threatening complications.

Mild reactions occur in up to 10% of patients and typically include warmth, flushing, altered taste (often described as metallic), nausea, or mild urticaria. These symptoms are self-limiting and usually resolve without intervention within minutes.

Moderate reactions—such as more pronounced urticaria, bronchospasm, or vasovagal responses—are less common (<1%) and may require pharmacologic support, including antihistamines or bronchodilators. Severe reactions—including laryngeal edema, profound hypotension, or anaphylactic shock—occur in fewer than 0.04% of cases and necessitate immediate emergency management with epinephrine, airway support, and intravenous fluids.

Non-allergic mechanisms also contribute to risk. Contrast-induced nephropathy—a transient decline in renal function—is a particular concern in patients with preexisting chronic kidney disease, diabetes, or dehydration. Serum creatinine should be assessed before administration in at-risk individuals, and hydration protocols are routinely recommended.

Other considerations include thyroid dysfunction in susceptible patients (due to iodine load), especially those with underlying Graves’ disease or multinodular goiter, and rare instances of contrast extravasation causing local tissue irritation or compartment syndrome. Radiology teams employ rigorous screening, risk stratification, and real-time monitoring to mitigate these risks and ensure patient safety.